Sacubitril/valsartan as a Treatment for Resistant Hypertension in Patients With Heart Failure and Preserved Ejection Fraction

被引：0
|
作者：
Jhund, Pardeep S.
Alice, M.
Pfeffer, Marc A.
Zannad, Faiez
Lefkowitz, Martin P.
Shi, Victor
Vardeny, Orly
Solomon, Scott
McMurray, John J.
机构：
来源：
CIRCULATION | 2020年 / 142卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A16477
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Focused Treatment of Heart Failure with Reduced Ejection Fraction Using Sacubitril/Valsartan
    Rex C. Liu
    American Journal of Cardiovascular Drugs, 2018, 18 : 473 - 482
  • [42] Medical Treatment of Hypertension in Patients with Heart Failure with Preserved Ejection Fraction
    Kiel, Richard G.
    Deedwania, Prakash
    CURRENT CARDIOLOGY REPORTS, 2013, 15 (12)
  • [43] LBCT: Effects of Sacubitril/Valsartan in Women Compared to Men With Heart Failure and Preserved Ejection Fraction
    McMurray, John J.
    Lam, Carolyn S.
    McGrath, Martina
    Pardeep, Jhund S.
    O'Meara, Eileen
    Packer, Milton, Jr.
    Redfield, Margaret M.
    Shi, Victor
    Sweitzer, Nancy K.
    Solomon, Scott D.
    CIRCULATION, 2019, 140 (25) : E994 - E995
  • [44] Medical Treatment of Hypertension in Patients with Heart Failure with Preserved Ejection Fraction
    Richard G. Kiel
    Prakash Deedwania
    Current Cardiology Reports, 2013, 15
  • [45] The interplay between sacubitril/valsartan, heart failure with preserved ejection fraction, diabetes and kidney function
    Voordes, Geert H. D.
    Heerspink, Hiddo J. L.
    ter Maaten, Jozine M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (05) : 804 - 806
  • [46] Sacubitril/Valsartan in the primary treatment of heart failure with reduced ejection fraction (HFrEF)
    Nowak, Bernd
    Geiss, Ernst
    Boehm, Michael
    Weil, Joachim
    Boer, Jana
    KARDIOLOGIE, 2023, : 44 - 48
  • [47] Current evidence of sacubitril/valsartan in the treatment of heart failure with reduced ejection fraction
    Abumayyaleh, Mohammad
    El-Battrawy, Ibrahim
    Behnes, Michael
    Borggrefe, Martin
    Akin, Ibrahim
    FUTURE CARDIOLOGY, 2020, 16 (04) : 227 - 236
  • [48] DAPAGLIFLOZIN VERSUS SACUBITRIL-VALSARTAN FOR HEART FAILURE WITH MILDLY REDUCED OR PRESERVED EJECTION FRACTION
    Arbel, Ronen
    Oberoi, Mansi
    Alnsasra, Hilmi
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 628 - 628
  • [49] Dapagliflozin versus sacubitril-valsartan for heart failure with mildly reduced or preserved ejection fraction
    Arbel, Ronen
    Azab, Abed N.
    Oberoi, Mansi
    Aboalhasan, Enis
    Star, Artyom
    Elhaj, Khaled
    Khalil, Fouad
    Alnsasra, Hilmi
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [50] Focused Treatment of Heart Failure with Reduced Ejection Fraction Using Sacubitril/Valsartan
    Liu, Rex C.
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2018, 18 (06) : 473 - 482
12345